Scarica l'app Stockscreener
31.99
7.06%
2.11
Dopo l'orario di chiusura:
31.61
-0.38
-1.19%
Precedente Chiudi:
$29.88
Aprire:
$30.18
Volume 24 ore:
53,950
Relative Volume:
1.45
Capitalizzazione di mercato:
$225.34M
Reddito:
-
Utile/perdita netta:
$-4.98M
Rapporto P/E:
-24.28
EPS:
-1.3177
Flusso di cassa netto:
$-3.85M
1 W Prestazione:
+23.09%
1M Prestazione:
+14.25%
6M Prestazione:
-0.31%
1 anno Prestazione:
+2,459%
Intervallo 1D:
$29.28
$32.64
Intervallo di 1 settimana:
$25.56
$32.64
Portata 52W:
$0.94
$79.02
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Nome
Bright Minds Biosciences Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta DRUG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DRUG
Bright Minds Biosciences Inc
|
31.99 | 211.65M | 0 | -4.98M | -3.85M | -1.3177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-13 | Iniziato | TD Cowen | Buy |
| 2025-05-07 | Iniziato | Chardan Capital Markets | Buy |
| 2025-01-23 | Iniziato | Piper Sandler | Overweight |
| 2025-01-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-01-10 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-26 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Bright Minds Biosciences Inc Borsa (DRUG) Ultime notizie
Bright Minds Biosciences Inc. Stock Analysis and ForecastGame-changing capital returns - Autocar Professional
Brokerages Set Bright Minds Biosciences Inc. (NASDAQ:DRUG) Price Target at $83.25 - Defense World
What drives Bright Minds Biosciences Inc. stock priceFree Stock Market Beginners Guide - Autocar Professional
Is Bright Minds Biosciences Inc. a good long term investmentFree Investment Portfolio Suggestions - Autocar Professional
What analysts say about Bright Minds Biosciences Inc. stockUnrivaled growth potential - jammulinksnews.com
Why Bright Minds Biosciences Inc. stock attracts strong analyst attentionFree Stock Market Practical Discussion Forums - Newser
How Bright Minds Biosciences Inc. stock performs during market volatilityVerified Chart Patterns - Newser
(DRUG) Investment Analysis and Advice - news.stocktradersdaily.com
What drives TTAM stock priceHigh-yield investments - Jammu Links News
Can Bright Minds Biosciences Inc. stock recover from recent declineFree Top-Rated Stock Analysis - Newser
Does Bright Minds Biosciences Inc. stock pay reliable dividendsMoney Making Low Risk Plans - Newser
What makes Bright Minds Biosciences Inc. stock price move sharplyRisk Controlled Trading Ideas - Newser
Why TBCH stock attracts strong analyst attentionTop Momentum Stock Pick - Newser
How To Trade (DRUG) - news.stocktradersdaily.com
Cantor Fitzgerald Forecasts DRUG FY2025 Earnings - Defense World
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Given Consensus Rating of “Buy” by Analysts - Defense World
4,793 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Acquired by Bank of America Corp DE - Defense World
DRUG FY2025 EPS Forecast Raised by Cantor Fitzgerald - Defense World
Bright Minds Biosciences (NASDAQ:DRUG) & SCYNEXIS (NASDAQ:SCYX) Head-To-Head Survey - Defense World
6,600 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Acquired by Jane Street Group LLC - Defense World
40,379 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Purchased by Millennium Management LLC - Defense World
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of “Buy” from Analysts - Defense World
Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times
Bright Minds Showcases Revolutionary CNS Drug Portfolio at Major Jefferies Healthcare Conference - Stock Titan
Bright Minds Biosciences Inc Azioni (DRUG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):